U.S Physical Therapy Net Worth 2010-2024 | USPH

Interactive chart of historical net worth (market cap) for U.S Physical Therapy (USPH) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. U.S Physical Therapy net worth as of May 05, 2025 is $1.1B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.097B $0.671B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.823B 19.53
Encompass Health (EHC) United States $11.724B 24.85
DaVita (DVA) United States $10.882B 14.45
Chemed (CHE) United States $8.428B 26.49
Option Care Health (OPCH) United States $5.373B 23.95
Elanco Animal Health (ELAN) United States $4.791B 10.60
RadNet (RDNT) United States $3.985B 84.33
Amedisys (AMED) United States $3.159B 21.25
LifeStance Health (LFST) United States $2.574B 0.00
Addus HomeCare (ADUS) United States $1.920B 21.08
Astrana Health (ASTH) United States $1.816B 36.39
Pennant (PNTG) United States $0.928B 37.14
Aveanna Healthcare Holdings (AVAH) United States $0.925B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00